Press releases

A biomarker for cancer of the oropharynx

3. April 2017

A growing number of cases of oropharyngeal cancer are considered to be a consequence of infection with human papillomaviruses (HPV). Scientists at the German Cancer Research Center (DKFZ) have now revealed that a single blood sample test for specific antibodies can identify persons who are at a high risk of developing this type of cancer ten years or more before cancer diagnosis. More ...

Prognostic Marker Found for Oropharyngeal Cancer

02. May 2013

In cancers of the oropharynx, a specific pattern of chemical tags in tumor cell DNA indicates a favorable prognosis. This so-called “epigenetic signature” predicts disease progression more reliably than previously used prognostic criteria. Patients with a predicted favorable prognosis could be treated less intensively. This was reported by scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital. More ...

Biomarkers for virus-induced cancer in the oropharynx

20. September 2012

Patients with oropharyngeal cancers have a more favorable prognosis if their tumors are caused by human papillomaviruses. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University Hospital have now identified biomarkers which enable them to differentiate cancer cases taking a favorable course from those with an unfavorable one. It may be possible to treat the two disease types differently. More ...

Roche and the German Cancer Research Center (DKFZ) Enter Collaborative Research Agreement to Identify New RNA Biomarkers that Help Predict Cervical Cancer Risk

11. October 2010

Collaboration is based on recent DKFZ discovery suggesting cervical cancer risk may be more precisely determined by relative amounts of particular spliced HPV RNA molecules. More ...

New Test for Safer Biomedical Research Results

30. July 2009

In biomedical research with living cells in the culture dish, contamination with bacteria, viruses or other fast-growing cells is always a problem. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now developed a test system for fast and cost-effective detection of such contaminations. The new method will contribute to making biomedical research results safer and reproducible. More ...

Promising HPV Test: Fast, Precise and Low-Cost

06. February 2006

Researchers at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in the group of Markus Schmitt have developed a detection method for human papilloma¬viruses (HPV) which allows them to identify, in a quick and highly reliable manner, high-risk viruses that cause cervical cancer.  More ...

to top